Raymond James Financial Inc. Takes Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Raymond James Financial Inc. purchased a new stake in Pediatrix Medical Group, Inc. (NYSE:MD) in the 4th quarter, Holdings Channel reports. The fund purchased 233,657 shares of the company’s stock, valued at approximately $3,066,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Quest Partners LLC raised its holdings in Pediatrix Medical Group by 25.6% during the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after purchasing an additional 622 shares during the last quarter. Intech Investment Management LLC raised its holdings in Pediatrix Medical Group by 29.6% in the third quarter. Intech Investment Management LLC now owns 40,662 shares of the company’s stock valued at $471,000 after buying an additional 9,289 shares during the period. Algert Global LLC purchased a new stake in Pediatrix Medical Group during the 3rd quarter worth $1,315,000. FMR LLC grew its position in Pediatrix Medical Group by 220.6% in the third quarter. FMR LLC now owns 9,841 shares of the company’s stock valued at $114,000 after acquiring an additional 6,771 shares in the last quarter. Finally, BNP Paribas Financial Markets lifted its holdings in Pediatrix Medical Group by 141.2% in the 3rd quarter. BNP Paribas Financial Markets now owns 18,520 shares of the company’s stock worth $215,000 after buying an additional 10,843 shares in the last quarter. Institutional investors and hedge funds own 97.71% of the company’s stock.

Pediatrix Medical Group Price Performance

Shares of MD opened at $14.15 on Friday. The stock’s fifty day moving average is $14.40 and its 200-day moving average is $13.65. The firm has a market capitalization of $1.21 billion, a price-to-earnings ratio of -11.79, a price-to-earnings-growth ratio of 1.74 and a beta of 1.49. Pediatrix Medical Group, Inc. has a one year low of $6.62 and a one year high of $17.67. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The company had revenue of $502.36 million for the quarter, compared to the consensus estimate of $486.22 million. Equities analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Analyst Upgrades and Downgrades

MD has been the topic of several recent analyst reports. Macquarie started coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They issued an “outperform” rating and a $18.00 price target on the stock. Truist Financial boosted their price objective on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research report on Friday, February 21st. UBS Group upped their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a report on Friday, February 21st. Finally, StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $17.08.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.